- Home
- XBIO vs DATS Comparison
XBIO vs DATS Comparison
Compare XBIO & DATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- DATS
- Stock Information
- Founded
- XBIO N/A
- DATS 2014
- Country
- XBIO United States
- DATS United States
- Employees
- XBIO N/A
- DATS N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- DATS Computer Software: Prepackaged Software
- Sector
- XBIO Health Care
- DATS Technology
- Exchange
- XBIO Nasdaq
- DATS Nasdaq
- Market Cap
- XBIO 6.3M
- DATS 5.2M
- IPO Year
- XBIO N/A
- DATS 2021
- Fundamental
- Price
- XBIO $4.06
- DATS $1.72
- Analyst Decision
- XBIO Hold
- DATS
- Analyst Count
- XBIO 1
- DATS 0
- Target Price
- XBIO N/A
- DATS N/A
- AVG Volume (30 Days)
- XBIO 22.9K
- DATS 388.5K
- Earning Date
- XBIO 11-12-2024
- DATS 11-14-2024
- Dividend Yield
- XBIO N/A
- DATS N/A
- EPS Growth
- XBIO N/A
- DATS N/A
- EPS
- XBIO N/A
- DATS N/A
- Revenue
- XBIO $2,523,427.00
- DATS $515.00
- Revenue This Year
- XBIO N/A
- DATS N/A
- Revenue Next Year
- XBIO N/A
- DATS N/A
- P/E Ratio
- XBIO N/A
- DATS N/A
- Revenue Growth
- XBIO 7.15
- DATS N/A
- 52 Week Low
- XBIO $2.78
- DATS $1.01
- 52 Week High
- XBIO $5.20
- DATS $4.13
- Technical
- Relative Strength Index (RSI)
- XBIO 52.07
- DATS 48.32
- Support Level
- XBIO $3.92
- DATS $1.65
- Resistance Level
- XBIO $4.27
- DATS $1.81
- Average True Range (ATR)
- XBIO 0.25
- DATS 0.16
- MACD
- XBIO -0.04
- DATS -0.03
- Stochastic Oscillator
- XBIO 38.45
- DATS 25.00
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts, even after they are sent.